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Neglected Tropical Diseases (NTDs) are both drivers and manifestations of poverty and social inequality. Increased
advocacy efforts since the mid-2000s have led to ambitious new control and elimination targets set for 2020 by the
World Health Organisation. While these global aspirations represent significant policy momentum, there are
multifaceted challenges in controlling infectious diseases in resource-poor local contexts that need to be acknowledged,
understood and engaged. However a number of recent publications have emphasised the “neglected” status of applied
social science research on NTDs. In light of the 2020 targets, this paper explores the social science/NTD literature
and unpacks some of the ways in which social inquiry can help support effective and sustainable interventions.
Five priority areas are discussed, including on policy processes, health systems capacity, compliance and resistance
to interventions, education and behaviour change, and community participation. The paper shows that despite
the multifaceted value of having anthropological and sociological perspectives integrated into NTD programmes,
contemporary efforts underutilise this potential. This is reflective of the dominance of top-down information flows
and technocratic approaches in global health. To counter this tendency, social research needs to be more than an
afterthought; integrating social inquiry into the planning, monitoring and evaluating process will help ensure that
flexibility and adaptability to local realities are built into interventions. More emphasis on social science perspectives
can also help link NTD control to broader social determinants of health, especially important given the major social
and economic inequalities that continue to underpin transmission in endemic countries.
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Influenced by certain ecological conditions and transmit-
ted through various vectors and animals, Neglected Trop-
ical Diseases (NTDs) are a heterogeneous group of some
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unless otherwise stated.burden the poor and marginalised in developing countries
where they cause much human suffering and poverty.
One billion people, referred to as the “bottom billion”, are
estimated to be infected by the seven most prevalent
NTDs (schistosomiasis, trachoma, soil-transmitted hel-
minths, lymphatic filariasis and onchocerciasis) in over
100 countries [1-3]. Taken together, NTDs are thought to
be second to HIV/AIDS in terms of infectious disease bur-
den yet they receive only a small proportion of develop-
ment assistance allocated to health [4]. The impact of
these infectious pathogens is often difficult to quantify
due to under-reporting, focal clustering, poly-parasitism,
diverse morbidity, stigmatisation and multifaceted influ-
ences on local livelihoods. Although notable gaps in con-
trol and treatment tools remain, many NTDs have a
practical “toolbox” of control options; this ranges fromThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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trol, active case detection and treatment, targeting of the
animal reservoir, environmental modification and im-
provements in housing, water, hygiene and sanitation [2].
Since the early-2000s, advocacy efforts have increased
greatly for NTDs, and these “forgotten afflictions” have
become somewhat less neglected in the global health
landscape [3]. Much of this new attention has been
driven by policy narratives that have framed NTD con-
trol as an avenue towards addressing global inequity and
poverty through cost-effective but big impact interven-
tions – what have been termed “low-hanging fruit”. Such
advocacy has relied heavily on the “value for money” of
the integrated control of parasitic worms through mass
drug administration (MDA) [5,6]. NTD control has been
linked to meeting multiple Millennium Development
Goals (MDGs); numerous public-private partnerships,
greater funding into scientific research and drug/diagnos-
tic product development, significant donation of medicines
by the pharmaceutical industry, and new and reinvigorated
donor and country programmes have followed. Illustrative
of this global momentum, the World Health Organisation
(WHO) Director-General, Dr Margaret Chan, has called
NTD efforts a “Cinderella tale…of moving from rags-to-
riches” [7]. Both the London Declaration in 2012 and a
landmark WHO resolution in 2013 signified the political
and financial commitment of endemic country govern-
ments and key donors (i.e. USAID, Gates Foundation and
DFID) to support ambitious new targets for control and
elimination set for 2020 [8,9]; these are summarised in
Table 1 for all 17 major NTDs.
Despite this enthusiasm, numerous challenges to meet-
ing these new targets exist. These involve both technical
questions about the efficacy of existing tools as well as op-
erational issues in moving global health interventions
from international boardrooms into socio-economically
and politically marginalised communities. Invoking the
classic dichotomisation between “top-down” and “bottom-
up” public health approaches, Spiegel and others [10] have
argued that current NTD programmes over-prioritise
narrow technical solutions at the expense of prevention
efforts and broader engagement with the social determi-
nants of health. Debates have emerged most visibly in
the rapid scaling-up of integrated MDA, which treated a
reported 887.8 million people in 2009 [3,11]. Some have
questioned the scientific evidence-base of the MDA
strategy [12], potential development of drug resistance
[13], the feasibility of integrating several existing pro-
grammes [14], the effectiveness of using unpaid volun-
teers [15], negative effects on health systems [16], and
local resistance and non-compliance with free treat-
ments [17-21]. In the absence of integrating MDA with
other strategies (i.e. water, hygiene and sanitation im-
provements, case management and vector control) othershave argued that underlying causes are left unaddressed,
perpetuating a “drug dependence” on preventative chemo-
therapeutic treatments [22-24]. The WHO itself has
acknowledged a number of complex risks that threaten
the feasibility of meeting the 2020 NTD targets; these
range from socio-political trends, challenges in vector
control, lack of local health system capacity, various
scientific gaps and the limited amount of funding being
allocated for implementation research [2].
Current debates reveal that despite policy narratives
centered on the poverty-inducing effects of NTDs, rela-
tively little research is being promoted, or undertaken,
on how the context of poverty and marginalisation influ-
ences the effectiveness and outcome of control/elimin-
ation/eradication programmes [25]. Diseases of poverty
are, by definition, both drivers and manifestations of
poverty. They reflect not only individual risk factors, but
larger structural inequalities in access to health services,
infrastructure, food security, education, political voice
and markets that drive poverty and maintain social and
economic exclusion [26,27]. Within these resource-poor
settings, this context of poverty will invariably dictate
how NTD interventions are implemented as well as the
particular ways in which disease control technologies are
adopted and used (or not used) by local health systems
and target populations. In short, the same poverty-
inducing factors that drive NTD transmission present
various context-specific challenges to controlling them.
There is an increasing emphasis in global health to
address the gap between the scientific efficacy of tools
and strategies and their practical translation and impact
into different local contexts – the so-called “implemen-
tation gap”. Optimising the impact of existing pro-
grammes is arguably one of the most cost-effective
funding strategies that international agencies and na-
tional governments can take [28]. In the field of NTDs,
the Special Programme for Research and Training in
Tropical Diseases (TDR) – funded by UNICEF/UNDP/
World Bank/WHO – has coordinated and funded much
ground-breaking implementation research going back
to the 1970s. Through training and small grants, TDR
has stimulated the development of social and economic
research into tropical diseases, brought social scientists
into collaborative arrangements with biomedical scien-
tists (especially on malaria, schistosomiasis and oncho-
cerciasis) and worked to highlight otherwise overlooked
areas, such as the importance of gender and community
participation [29]. Acknowledging this contribution,
two recent reports partially funded by TDR – Imple-
mentation Research for the Control of Infectious Diseases
of Poverty in 2011 and The Global Report for Research
on Infectious Diseases of Poverty in 2012 – have empha-
sised the need for greater emphasis on implementation
research in NTD control [30,31]. These reports were
Table 1 Major NTD control targets set for 2020 by WHO
NTD WHO Target [1]
Dengue “With new tools for diagnosis and vector
control, better case management and focused
research…an integrated vector management
approach should reduce rates of morbidity by
at least 25% and of mortality by 50% by 2020.”
Rabies “Elimination of human rabies transmitted by
dogs and dog-to-dog transmission is achievable
by 2015 in all endemic areas in Latin America;
and by 2020 in all affected countries in WHO’s
South-East Asia and Western Pacific regions.”
Trachoma “…global elimination goal by 2020…By 2020,
all countries will have achieved the UIG and be
free from blinding trachoma as a public-health
problem, and by 2020, 75% of countries will
have been verified as free from blinding
trachoma as a public-health problem.”
Buruli ulcer “WHO aims to cure 70% of all cases with
antibiotics in all endemic countries by 2020.”
Endemic
treponematoses
“Elimination of yaws in Africa is feasible by 2020,
therefore leading to global eradication”
Leprosy “Vigorous case finding and treatment would lead
to global interruption of transmission by 2020.”
Chagas disease “A milestone will be reached when peri-
domiciliary infestation has been eliminated
in Latin America by 2020.”
Human African
Trypanosomiasis
“…eliminate the disease in 80% of foci by 2015
and achieve elimination in 100% of foci by 2020.”
Leishmaniasis “WHO aims to detect at least 70% of all cases
of cutaneous leishmaniasis and treat at least
90% of all detected cases in the Eastern
Mediterranean Region by 2015. With sustained
efforts on the Indian sub-continent, 100% case-
detection and treatment of visceral leishmaniasis
is feasible by 2020…”
Cysticercosis “A validated strategy for the control and
elimination of Taenia solium taeniasis/
cysticercosis will be available by 2015; and
interventions for control and elimination scaled
up in selected countries in Africa, Asia and Latin
America by 2020.”
Dracunculiasis “Dracunculiasis is now on the verge
of eradication.”
Echinococcosis “Pilot projects to validate the effectiveness of
echinococcosis/hydatidosis control strategies will
be implemented in selected countries by 2015.
Scale up of interventions in selected countries in
Central Asia, North Africa and Latin America for
control and elimination as a public-health
problem will be in place by 2020.”
Foodborne
trematode infections
“By 2020, 75% of the at-risk population will have
been reached by preventive chemotherapy and
morbidity associated with foodborne trematode
infections will be under control in 100% of the
endemic countries.”
Lymphatic filariasis “By 2020, 100% of all endemic countries will
have been verified as free of transmission or will
have entered post-intervention surveillance.”
Table 1 Major NTD control targets set for 2020 by WHO
(Continued)
Onchocerciasis “It is currently estimated that, by 2020, 12 APOC
countries and 11 ex-OCP countries may have
achieved elimination, out of a total of 31
countries affected…”
Schistosomiasis “…could be eliminated as a public health
problem in multiple countries in Africa by 2020,
and globally by 2025.”
Soil-transmitted
helminthiases
“…75% coverage will be reached in all
countries by 2020.”
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animal and ecosystem health as articulated by the “One
World, One Health” movement and outlined a new
trans-disciplinary vision for addressing, among other
things, the social determinants of health and illness –
and hence promoted the greater involvement of social
scientists [32].
However there are a number of difficulties in realising
this agenda. As with global health more generally, fund-
ing for NTDs is heavily concentrated on biomedical
research and, to a lesser degree, pharmaceutical industry
support for drug development [10,33,34]. Requiring
multidisciplinary teams and new sorts of methodologies,
part of the “neglect” of implementation research has to do
with the fact that it often not considered a “serious sci-
ence” [34-36]. The actual translation of such research into
more effective interventions is also complex and uncer-
tain. Research on gaps between policy, programmes and
target populations regularly encounter barriers to being
incorporated into particular programmes or the larger
health system landscape; hence simply conducting re-
search on the “implementation gap” does not mean oper-
ational practices will change and be improved.
One of the major dimensions to the implementation–
NTD nexus relates to the level of involvement of so-
cial scientists – particularly sociologists and anthro-
pologists – in interventions. Disjunctions between
biomedicine and social research have traditionally
been maintained by disciplinary (and epistemological)
differences as well as working norms, systems of re-
ward and grant funding cycles [36-39]. Despite efforts
dating back to the 1970s [29,39-41], a number of re-
cent publications (some commissioned by TDR itself )
have criticised the contemporary NTD landscape for
a lack of social inquiry and consideration of local contexts
in devising and implementing control programmes
[17,21,25,42-45]. In many ways, these publications have
reiterated old debates about the limited cross-fertilisation
between biomedical and social scientists. Allotey et al.
[43] summarily stated that “research and interventions
for neglected tropical diseases, largely neglect the social
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eases persist in the target populations” and that social
research, when it is conducted, is largely “hand-maiden”
to biologically-defined solutions and perspectives. An-
other recent paper claimed that the epistemic commu-
nities working on NTDs and social determinants have
been largely “passing in the night” with little direct contact
[44]. A bibliographical analysis of research publications
emphasised that the social sciences are being “under-
prioritised” and “neglected” by the contemporary NTD re-
search and programme landscape [42]. Tensions have
most vividly been shown in a series of publications, in-
cluding in The Lancet (the prestigious UK medical jour-
nal), between anthropologists, who found community
resistance to MDA in Uganda and Tanzania, and some
longstanding NTD advocates based at the WHO and
elsewhere [3,11,17,45].
The aims of this paper are to move beyond polarising
statements about the lack of social science research on
NTDs; the paper attempts to stimulate critical debate
about what types of studies have already been conducted
and what they show us about how applied social inquiry
can contribute towards supporting the 2020 targets.
Using the NTD–specific literature, the paper explores
some of the major challenges facing planners, imple-
menters and communities in sustainably controlling
NTDs and the barriers and bridges that require more
consideration. Moving conceptually from the global into
the local, it maps out five priority areas where applied
sociology and anthropology can best contribute to an
implementation research agenda, including on policy
processes, health systems capacity, community responses
to interventions, education and behaviour change and
community participation. Methodologically, the paper
does not attempt to systematically analyse the existing
literature, which would have proven to be a more com-
plex task considering the 17 NTDs. Rather it builds on
recent reviews of social science research and NTDs
mentioned above, including a bibliographical analysis of
existing literature for chikungunya, dengue, visceral
leishmaniasis, and onchocerciasis [42], NTDs and social
determinants [27] and NTDs and community participa-
tion [41]. It supplemented these data sources with sec-
ondary bibliographic searches of key journals and other
important publications, aiming to reference some of the
most insightful and representative academic publications
that engage with the challenges of NTD interventions.




The first priority area for social research involves policy
processes, which remain poorly understood in mostdeveloping economies and involve various components; a
useful framework developed by the Institute of Develop-
ment Studies (IDS), University of Sussex [46], divides pol-
icy processes into discourses/narratives, social networks
and politics/interests. Tied to a specified set of actors used
to mobilise resources, policy narratives often frame issues
in simplistic ways to reduce uncertainty and enrol support.
These are based on specific underlying assumptions that
create boundaries around an issue, define the limits of
action and what/who is to be included and excluded.
Neglected diseases largely persist in countries with
financial and human resource constraints. In a unique
study, Spiegel et al. [47] reported that a central bottleneck
in dengue control programmes related to value differences
between stakeholders and the ability for institutions to
adapt and learn from operational mistakes. More gener-
ally, bureaucratic norms and weaknesses in management
have been noted as one of the major binding constraints
in global health; highlighting this generally overlooked but
important area [48]. Kabaterine et al. [14] alluded to some
of these complexities in the African context when they
noted that restructuring several vertical programmes into
one integrated MDA programme could “cause resentment
among managers, in extreme cases leading to obstruction
and other difficulties in managing the process”. Such
human resources issues are embedded within different
socio-cultural, economic and political processes that
shape the governance and delivery of healthcare
services [49].
Understanding national policy contexts is essential to
adapting programmes from the global to national/local
level. Civil service and health system reforms (i.e. sector-
wide approaches, decentralisation and liberalisation) have
been shown to present unique challenges; as noted by
Cairncross et al. and Miri et al. in their analysis of the
lengthy process of dracunculiasis eradication in Ghana
and Nigeria [50,51]. National policy contexts also foster
differences in ministerial relationships between sectors
that complicate inter-sectoral programmes, especially im-
portant for zoonotic NTDs such as rabies, cysticercosis,
echinococcosis and Rhodesian sleeping sickness, as well as
multi-sectoral programmes on water, hygiene and sanita-
tion [52-54]. Complex fiscal relationships exist between
different levels of government both vertically (from central
to local) and horizontally (between ministries). Even
where legislation exists, mechanisms to ensure inter-
sectoral financial and operational responsibilities are often
lacking – shown in a recent study on a dengue outbreak
in Mexico [55]. Pharmaceutical liberalisation and the lack
of state regulation can also contribute to inherent tensions
between public health and other actors in the private
health system – see Bardosh et al.’s analysis of the veterin-
ary pharmaceutical market in sleeping sickness endemic
areas of Uganda [56].
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side the realm of the state: international agencies, univer-
sities, the private sector, philanthropic foundations,
international and national non-governmental organisations,
community-based organisations and others [57]. Funding
sources, institutional capacity and personal relationships
are central to driving partnerships forward, where partners
have different strengths and weakness, and power dynamics
influence operational practices [58]. While non-state inter-
ventions implemented, for example, by NGOs, universities
and the private sector can sometimes circumvent the
hurdles of state bureaucracies and resource-constraints,
long-term sustainability often demands state involvement
or integration within the general health system; leaving
the state behind, without capacity building, can create
long-term problems in sustainability.
These various social contexts present multifaceted
challenges to the scaling-up process. As discussed by a
recent paper describing a USAID integrated MDA initia-
tive in multiple African countries, scaling-up can involve:
organising a central coordination mechanism, stakeholder
engagement, situational analysis, action and work plans,
funding gap analysis, disease mapping and defining moni-
toring and evaluations criteria [59]. While constraints are
inevitable, their particulars are rarely subject to analytical
scrutiny and the little attention given to monitoring and
evaluation more generally risks limiting learning and
adaptation [60]. The need for programmes to “look good”
in order to attract donor-driven grant cycles have been
noted for structuring what issues are researched and how,
limiting opportunities to explore and discuss complex so-
cial and operational challenges [45].
Furthermore, the desire for results by donor agencies
over short project cycles have been noted to push pro-
grammes to go to scale too quickly and lead to poor mo-
bilisation, education and support for field staff. While a
major challenge is enabling flexibility to country-contexts
in NTD programmes that often have a global remit, ar-
guably more challenging is adapting to socio-cultural,
political, economic, infrastructural and environmental
differences between and within districts. Studies show
that despite trends towards decentralisation in local
government in many endemic countries, feedback and
responsiveness to local needs within the general health
systems are limited; this is perpetuated by planning and
managerial spheres being heavily centralised with little
decision-making capacity at the district level – as shown
by recent NTD studies in Tanzania, for example [61-63].
Transcending the classic “transplantation” problem in
global health – where standardised approaches do not
allow for context-specific strategies – requires thinking
beyond the technology transfer model to engage more
directly with local needs and the complexity of the
scale-up process [64].More than other areas, there is a dearth of research on
policy processes for NTDs. Analysis of the interrelation-
ships between global and national policy contexts, institu-
tional and organisational norms and values, the devolution
of power and information sharing, stakeholder incentives,
and the potential bottlenecks in service delivery networks
clearly require more attention. Such research can provide
valuable information to help manage NTD programmes,
build adaptability and learning into the scale-up process
and exploit the strengths of different policy actors. With
a variety of methodological and conceptual frameworks
available, systematic health policy research could play
important roles in informing NTD policy development
and programme implementation [46,65].
II. Programmes and health systems
The second, albeit interrelated, priority area involves
the interface between programmes and health systems.
Functioning primary healthcare systems are recognised
as essential to NTD control [66]. However neoliberal re-
forms in the late 1980s to “roll back the state” led to
drastic reductions in health (and veterinary) sector ex-
penditure in many developing countries [67]. At the
district-level, programmes operate where human re-
sources, information systems, essential drugs, basic in-
frastructure and supplies are often extremely limited.
Weak state and patron-client relationships place local-
level staff between the interests of the local and the na-
tional/global. The wider anthropological literature on
international development shows that policy itself has a
precarious influence on the operational practices of devel-
opment projects – including NTD interventions – which
are shaped more by organisational demands, norms and
relationships at the local level [68,69].
NTD programmes make use of health systems in three
general ways: integration within health services (used
for many leprosy programmes), structures completely
outside (most mobile sleeping sickness screening ser-
vices), and programmes organised by the central-level
but carried out by district staff (many current integrated
MDA programmes) [70]. There are both positive and
negative impacts of such programmes on the general
health system, ranging from effects on leadership and
governance, health information systems, financing, in-
frastructure and supplies, workforce and service deliv-
ery [71]. One way to avoid negative impacts is to take
account of resource-limitations and working norms
before projects attempt to “piggy-back” on existing
delivery networks; as shown by a scoping study on the
feasibility of Human African Trypanosomiasis elimin-
ation in Zambia [72].
The few in-depth studies on the relationships between
NTD programmes and health systems have shown dif-
ferent results. Baker et al. [73] reported a retrospective
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integration in the Dominican Republic. This required
adapting to national health sector reforms and decen-
tralisation, including using community volunteers to ac-
count for staff shortages. The authors reported that
integration substantially increased coverage of MDA
(despite initial difficulties) and strengthened information
systems and community engagement in the health
system, partially because key stakeholders were well
prepared for the integration process. Advocates of
community-driven ivermectin treatment for onchocer-
ciasis have argued that the approach strengthens primary
healthcare by giving control of decision-making to com-
munities, albeit providing the necessary resources and
support requires multiple years of re-trainings [74]. In
contrast, studies on leprosy programmes have shown the
reluctance of control staff to take on extra responsibil-
ities, the inadequacies of short trainings and variations
between districts/regions based on the quality of the
health system [75-77].
The few studies on MDA have also revealed significant
challenges. Cavalier et al. [16] documented the disruption
of access to general healthcare during integrated MDA in
Mali and the lack of funds for institutional strengthening.
A further ethnographic study in Tanzania commented on
how district-level health staff considered handling mul-
tiple NTD interventions simultaneously as more of a bur-
den than a cost-saving strategy [21]. Cairncross et al. [50]
discussed 13 years of stagnation in dracunculiasis eradica-
tion in Ghana (due partially to the implementation of a
sector-wide approach, government decentralisation and
staff transfers) while Balen et al. [78] drew attention to
more subtle social equity issues in China for schistosomia-
sis, where barriers to treatment were driven by the lack of
medical insurance among the poor, despite a well planned
and integrated programme.
Integrating programmes into the general health system
is in many cases necessary and desirable. This requires
vertical programme managers to navigate the political
landscape of the health system, foster clear understandings
of roles and responsibilities, and provide strategic training,
resources, supervision and support. Local health systems
remain frontline mediators between communities and
neglected pathogens long after many donor-funded pro-
jects end; hence examining their needs, capacities and
contexts should form an integral component of any
comprehensive NTD programme.
III. Community responses to interventions
A third key area for social inquiry to support NTD con-
trol involves community responses to interventions, par-
ticularly compliance and resistance. Among others, the
work of the political scientists James Scott [79,80] has
shown how the intended beneficiaries of scientificinterventions, including global health interventions,
challenge dominant knowledge claims through local re-
sistance, avoidance, noncompliance and strategic accom-
modation. Despite the best of intentions, technological
interventions seldom involve the unproblematic applica-
tion of scientific tools to local settings but invariably
provoke acts of reinterpretation as they engage with
local perceptions and experiences.
On the one end, the NTD literature shows that inter-
ventions are mediate by access barriers embedded within
geography, delivery schedules and differences between
population sub-groups. In a qualitative study, Mpanya
et al. [81] noted the discrepancies between the schedule
of a HAT mobile screening team and the movements of
diamond miners and farmers, which significantly low-
ered the number of people willing to be tested. The need
to tailor delivery strategies to different sub-populations
is a ubiquitous finding of most social studies; as shown
in the influence of gender on MDA [82], compliance of
pastoralists with canine vaccination for rabies [62] and
schistosomiasis control among fisherfolk [19]. Numerous
other access barriers have also been noted. Omedo et al.
[83] in Kenya argued that better coverage for schistosom-
iasis control would be achieved if MDA were carried out
during the harvest period to correspond with food avail-
ability to reduce side-effects. Coverage of ivermectin
treatment has been low due to discontinuities between
the working hours of health personnel and farming
schedules - a partial impetus for allowing community
volunteers to determine the period of treatment [74].
Furthermore, the success of case detection strategies
and surveillance, for example in visceral leishmaniasis
control in South Asia [84], can depend substantially on
whether communities prefer public or private health
systems and how projects engage with different pro-
viders. Clearly, conducting such studies prior to a bio-
medical research or control programme can avoid many
costly (and unnecessary) operational blunders.
However barriers to community compliance go well
beyond these more easily remedied operational issues
and a growing body of literature on “local resistance” to
global health interventions has emerged [85-87]. Resist-
ance is often deeply rooted in local frames of reference,
tied to social networks and related to wider socio-
political issues. Local understandings of disease, relation-
ships to government officials and the state, and past
experiences with development projects play important
mediating roles. For example, local perceptions about
drug toxicity, lack of confidentiality during screening
procedures and local beliefs about the costs of treatment
contributed to resistance to HAT screening in the DRC
[81]. Hastings [87] described how riots occurred after an
MDA programme in Tanzania due to fears that it was a
covert sterilization campaign, which resonated with local
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driven development projects. In fact, local resistance to
MDA has been reported in numerous studies in the
last few years [17-21,88-95]. A review of research for
lymphatic filariasis control identified: local fears over
treatment and side-effects, individual characteristics (in-
cluding mobility patterns), knowledge and awareness,
prior experiences with MDA and the training, motiva-
tions and characteristics of distributors [90]. Observing
the poor compliance rates for MDA in Ugandan schools,
Muhumuza et al. [94] proposed increasing health educa-
tion, teacher motivation and providing snacks. Others
have questioned the effectiveness of using teachers and
community volunteers where notions of medical expert-
ise are exclusively tied to health professionals [87,95]. A
more complicated picture was illustrated by ethno-
graphic fieldwork done by Parker and Allen [17-20] who
remarked on the need to link MDA drug distribution to
more holistic control approaches to legitimise it to re-
luctant community members – confused about why
they should swallow tablets when disease drivers remain
unaddressed.
Understanding livelihood patterns, migration, health
seeking behaviour, local knowledge and others social
processes at play among the “bottom billion” can help
tailor programmes to enhance community acceptability.
A major issue is the level of trust between recipient
communities and field staff and delivery networks, and
the degree to which interventions are tailored to local
concerns, perspectives and needs. Giving greater scope
to local voices would address many, but perhaps not
all, cases of “active resistance”. There is a need to aban-
don the simplistic, but safer, interpretation that non-
compliance is primarily about “lack of awareness” and
reflect more on the nature of the programme strategies
used and their wider socio-political context – what
has been called the political epidemiology of disease
control [96].
IV. Educating publics, changing behaviours
While risk behaviours have been widely emphasised by
social science studies on different NTDs [97,98] little re-
search has directly and systematically explored health
education, despite its importance for addressing non-
compliance. For example, the studies referred to above
on MDA are unanimous that certain information is fun-
damental to accompany MDA but have not been readily
incorporated into campaigns: Why do some experience
side-effects but others not? Why is praziquantel given by
height and not weight? Why do people without symp-
toms have to take drugs? Why is the programme not ad-
dressing water and sanitation? Education strategies play
a double role. They not only promote greater commu-
nity compliance by making people aware of the value ofparticipating in a given programme but they can also be
used to promote fundamental behaviour changes with
long-term implications.
There is a large literature on the complexities of devis-
ing and tailoring education and public engagement strat-
egies for health issues in developing country contexts;
the literature emphasises that messages should not only
be culturally acceptable but “culturally compelling” [99].
In a revealing study on malaria nets in Africa, Panter-
Brick et al. [100] showed the need to reinforce simple
messages over time using different mediums, gain com-
munity support and focus on positive outcomes while
also addressing constraints to people’s agency. Similarly,
based on his experience with guinea worm, Brieger [101]
emphasised moving beyond didactic methods to include
skills development, knowledge acquisition and active com-
munity involvement.
Few studies explore how existing national programmes
educate their publics for NTDs and how education cam-
paigns can move beyond small-scale, donor-funded re-
search projects. An ethnographic study in Cambodia on
the national dengue control program delivery at schools,
health centres and villages is a rare and insightful ex-
ample. Under-funded, irregularly implemented and sel-
dom evaluated, Khun and Manderson [102] reported on
various operational shortcomings, including little training
or incentives for health staff and teachers and confusing
messages that did not engage with local constraints to
behavioural change. The authors recommended schools
engage in community-based vector control outreach ac-
tivities to move beyond an otherwise passive education
model. The work of Parker and Allen [17-20] is also in-
formative. In Uganda and Tanzania, they found that
adults were increasingly rejecting free treatment for
schistosomiasis, lymphatic filariasis and soil-transmitted
helminths. Part of this involved health education used
by volunteers, school teachers and government officials
that did not engage with real and imagined fears of
side effects based on local aetiological concepts and sus-
picions about the motivation of the programme. Simi-
larly, Hastings [87] revealed how health education
accompanying an MDA programme in Tanzania did not
provide sufficient time for dissemination to parents and
local leaders. Influenced by time and budget restric-
tions, Burke [103] also noted the “top-down” planning
process used in Togo during an integrated MDA health
education strategy which did not engage with gender
dimensions, local understandings of disease, drug side-
effects and the rationale behind MDA, although com-
munity volunteers did adapt guidelines in practice.
Given emerging critiques of non-compliance to NTD
interventions, especially MDA, there is an urgent need
to explore how national NTD programmes are engaging
with community perceptions in health education and
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cerns. Although most of the NTD literature shows posi-
tive increases in knowledge through health education
[104-106], few studies explore the opportunities and
challenges involved in how education can be used to actu-
ally change behaviour – see El-Katsha and Watt’s superb
study on schistosomiasis in Egypt (with a focus on gender
differences) for an example [107]. There are deeply imbed-
ded barriers to behaviour changes that need to be consid-
ered and incorporated into educational strategies [108].
For example, the tensions between the public and private
goods aspect of vector control has been noted for why
people, otherwise knowledgeable about prevention prac-
tices, do not practice them [109,110]. Important differ-
ences between (sub-) populations may require different
strategies, based on gender, age, wealth and livelihoods
[111,112]. These differences maintain power dynamics at
the community-level that need to be understood. Broader
disjunctions between “knowing” and “doing” are also
structured by poverty, livelihood patterns and locally em-
bedded socio-cultural processes, which need to be more
thoroughly accounted for during the planning of interven-
tions. Finally, there is also clearly a need to consider the
fact that behaviour change, even within a well-designed
programme, may be unlikely to occur in politically and
economically-marginalised communities, at least for cer-
tain types of embedded behaviours. Broader changes in
economy, politics and social organization may be needed
as prerequisites for effective, long-term disease control.V. Fostering participation, tailoring programmes
The last priority area, intersecting with the others, relates
to community participation, which is often polarised
between dismissal and romanticisation. Engaging with
communities occurs in different ways depending on envi-
sioned goals and outcomes but is arguably the most
essential aspect of addressing local resistance and
fostering behaviour change. Rifkin [113] divided com-
munity involvement into a spectrum from passive com-
pliance oriented around a “target framework” to active
involvement in priority setting and planning focused on
“empowerment processes” where planners and implemen-
ters take on roles as facilitators. The NTD literature
shows this full spectrum of participatory strategies; for
example, mobilising households in triatomine surveil-
lance [114], controlling schistosomiasis through changes
in water contact [115] and irrigation system cleaning
[116], volunteer networks for guinea worm eradication
[117], and grassroots task forces for dengue control [118].
This literature shows us that without a sound understand-
ing of community dynamics guiding intervention planning
there is a risk that planners and implementers pursue re-
ductionist strategies.“Communities” rarely adhere to geographical locations,
which are composed of a diversity of sub-groups with
differences in needs, capacities and constraints. This
may present challenges for approaches that seek the
broad involvement of the community; for example,
community-led total sanitation (CLTS) – a participatory
sanitation programme where people are encouraged to
build their own locally-sourced pit latrines and recently
promoted by NTD advocates – may face challenges in
addressing entrenched gender dynamics in Africa [119].
While compelling, the wider development literature
points to numerous potential shortcomings when par-
ticipatory interventions are scaled-up from small-scale
successes: the tendency for marginalized groups to be
excluded, facilitators to dominant the process, lack of
awareness of conflicting interests at the community-level,
pressures for quick results and the use of self-interested
intermediates [120,121]. Perhaps more problematic is the
notion that community participation involves communi-
ties “doing it themselves” which overlooks the fact that
such interventions essential create new social networks
dependent on the implementing agency. The failure of
many community-driven tsetse trap projects popular in
the 1990s and 2000s is one example [110]. People were
willing, to varying degree, to contribute money, time and
effort but activities ceased in the absence of inputs and
state/NGO/academic coordination [122,123]. While some
have argued that technical experts hampered success by
never truly devolving ownership [123], poor farmers are
also reluctant to invest scarce resource and time into a
public good, especially once vector populations decline.
Past experiences with tsetse trap projects, and many
other participatory NTD efforts, questions the notion
that sustainability equates to the cessation of support
from the outside. Clearly, economic and political real-
ities reduce the resources, time and capacity of “the bot-
tom billion” to participate in disease control and seek
medical treatment in dynamic ways. Although this ques-
tions the idealistic notion that community members can
identify, prioritize and resolve their own health problems
[41], it also reinforces the need for community-led initia-
tives to help build societal resilience. Rather, sustainability
should be evaluated by how projects facilitate continued
linkages between communities and their local health
system, and other actors. One way to do this is to inte-
grate acceptable and efficacious strategies that resonate
broadly with the lives of poor people through addressing
sanitation, water, primary healthcare, housing and envir-
onmental management instead of narrowly focussing on
one specific pathogen – NTDs are only one problem
among many facing the lives of the poor.
Furthermore many successful programmes are built
not on mass community mobilisation but on enrolling
the support of key actors at the community-level. Much
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provided and the level of devolved priority setting and
planning. The most well documented example for an
NTD involves community-directed ivermectin treatment
for onchocerciasis in Africa, emerged from a lengthy
process of operational trial, error, learning and adapta-
tion since the 1980s [74]. Volunteers are selected by the
community, trained and given ownership over determin-
ing the period and mode of annual treatment. Although
financial incentives are rarely provided, social status
(recognition, self-fulfilment and political influence) and
meals, books and labour from recipients act as import-
ant non-monetary incentives [124,125]. The motivation
and support offered to volunteers clearly impacts cover-
age. Emukah et al. [126] reported on the high drop-out
rate of distributors in Nigeria (at least 35%) related to a
lack of incentives and supervision, long travel distances,
other duties and poor supply of ivermectin. Other stud-
ies have commented on the fact that higher coverage is
maintained by volunteers living closer to the communi-
ties they serve and being responsible for fewer house-
holds [124,127]. The involvement of women in
patriarchal societies is also a significant operational issue
[128] while volunteers can be overburdened and/or dis-
suaded by other community-based activities (such as
polio vaccination) where money is provided [129]. Varia-
tions between countries based on the strength of the
health system have also been noted [124].
There are a number of areas for implementation re-
search to explore innovative and practical ways for com-
munity participation to enhance NTD efforts. The first
is how existing community participatory strategies, for
example volunteer networks in ivermectin, can strengthen
primary healthcare which, despite much discussion, has
not been the subject of in-depth social studies. Arguably,
greater resources and support are required to be chan-
nelled to the community-level for this to be realised.
Second, there are few examples of projects that seek
to engage different actors in multi-stakeholder strategies
where different concerns and interests are incorporated
into the planning process. For example, a dynamic 10 year
action-research process for the control of cystic echino-
coccosis in Nepal moved from biomedical strategies to fo-
cussing on garbage collection policy and urban renewal
through a stakeholder engagement process [130]. Other
multifaceted examples include the control of dengue in
Latin America [131] as well as a 15 year partnership be-
tween mobile pastoralists, government authorities and the
Swiss Tropical and Public Health Institute in the Sahel
[132]. Studies should more systematically evaluate their
feasibility and benefits as a way to strengthen relationships
between communities, social service providers and donor-
projects. Third, there is a widespread lack of acknowledge-
ment of the types of participatory interventions that aremost effective in NTD control and how they can be scale-
up efficiently. To address this, social science research is
needed to devise new methodologies to measure behav-
iours, change processes and social impact in order to pro-
vide the evidence-base for incorporating community
participation into mainstream NTD programmes, while
also avoiding the tendency for participation to become a
technocratic, tick-the-box exercises [133]. Fourth, there
remains much scope to explore the shortcomings of how
contemporary interventions are engaging communities,
where social scientists can address barriers and propose
new strategies, preferably as part of a long-term engage-
ment strategy in collaboration with biomedical and public
health experts [134].
Conclusions
This paper has discussed a range of social dynamics in-
volved in moving global health interventions from man-
agement boardrooms in Geneva, London, Washington,
Nairobi, Bangkok and elsewhere to the many tens-of-
thousands of villages and slums where Neglected Tropical
Diseases persist among marginalised populations. Given
recent targets set for 2020, the coming years will see many
programmes expanded and scaled-up. However as this
paper has shown, there are fundamental and multifaceted
challenges facing planners, implementers and communities
in sustainably controlling NTDs. Pre-empting and address-
ing these as part of a critically engaged social science re-
search agenda is an essential aspect of good science, sound
management and global ethics. The Global Report for
Research on Infectious Diseases of Poverty (2012) outlined a
compelling rationale for addressing gaps in implementation
[30,31]. However such conceptually sophisticated plans
themselves have barriers to uptake and diffusion related to
funding priorities, expertise, the level of collaborative work
between social and biomedical scientists and the ability for
research to influence policy and practice [32-40].
Apart from discussing specific research areas where the
social sciences can support interventions (see below for a
summary), this paper also makes a number of implicit and
interrelated arguments; these are supported not only by
the existing NTD social science literature (including the
conclusions of many of the above cited research papers)
but also the wider anthropological literature on global
health [85,86,135-137]. The first relates to the fact that,
while insightful social research has certainly been con-
ducted on many NTDs, such research continues to be
relatively marginal compared to biomedically-orientated
priorities and perspectives. This general lack of social
inquiry on control programmes serves as a proxy for the
nature of information and knowledge flows in the NTD
global network. Good social inquiry engages in multidi-
mensional ways with the complexities of a given real world
problem as embedded within its socio-cultural, economic,
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time talking with people, asking difficult questions, chal-
lenging common assumptions, incorporating and making
sense of divergent views and generating novel interpreta-
tions based on “thick descriptions”. It involves under-
standing the local in context and as process. Such inquiry
helps to transform amorphous and compliant “popula-
tions” into active “publics” who have agency, opinions and
contexts that shape how they view and engage with out-
side plans and strategies [138]; in short, it offers the “bot-
tom billion” a chance to become involved in global health
governance and assist in setting priorities and tailoring
programmes.
Priority areas for social research to support NTD
control
1. Policy Processes
 How global/national policy contexts influence
NTD interventions
 What institutional and organisational norms
and values mediate programme operations
 The devolution of power and information
sharing between partners
 Social dynamics of data generation and use
 Stakeholder incentives and drivers
 Assumptions and narratives around scaling-up
2. The Interface Between Programmes and Health
Systems
 Existing resource-limitations and working norms
of health systems
 Needs, capabilities and context of the primary
health system and implementers
 Ways to synchronise programme goals with
primary health system strengthening
 Effects of interventions on general health services
3. Community Responses to Interventions
 Access barriers, such as how geography,
sub-populations and delivery schedules
influence delivery
 Incentives for implementers to deliver interventions
 How local understandings of disease, livelihood
patterns and other social processes influence
coverage and adoption of health technologies
4. Education and Behaviour Change
 The social, cultural, political and economic
barriers to behavioural changes
 Needs of differences sub-populations for
tailored strategies
 How existing national programmes educate
their publics
 How education strategies can move beyond
small-scale, donor-funded projects to be
scaled-up effectively5. Community Involvement and Participation
 Social diversity at the community level and how
it affects participatory processes
 Scope to link NTD control with wider issues in
sanitation, water, primary healthcare, housing
and environmental management
 Feasibility and processes involved in
multi-stakeholder engagement strategies
 The shortcomings of how contemporary
interventions are conceptualising and engaging
communities
 The trade-offs between short-term and
long-term community engagement
However in global health more generally, class and
cultural barriers between global and local actors reinforce
an unequal power dynamic (itself a representation of glo-
bal poverty and inequality) whereby the flow of knowledge
and information goes downwards from the global to the
local but little evaporates upwards, at least outside epi-
demiological data, coverage numbers and risk factor stud-
ies [135]. If programmes are to be truly “pro-poor” then
this power dynamic should be acknowledged and ad-
dressed more proactively by incorporating the voices,
opinions, experiences and capacities of the “bottom bil-
lion” more explicitly into policies and programmes, and
fostering more people-centric interventions. Otherwise
global NTD policy narratives can begin to replicate in-
equality – or even colonial discourses of the “other” – by
objectifying the very people they seek to assist. As noted
by Vlassoff [40] more than two decades ago, tropical dis-
ease interventions can all too easily over-emphasise a nar-
row focus on pathogens and technologies, neglecting
social perspectives.
If local realities are to be better linked to technical
solutions then a re-conceptualisation among biomedical
scientists, donors and ministerial officials that the “soft
sciences” only provide “anecdotal” evidence, is only use-
ful in uncovering “exotic cultural practices” and consists
of “nothing but” a standardised questionnaire is needed.
Despite decades of (continuing) research funding (i.e. by
TDR) aimed at fostering multidisciplinary teams and
collaboration between social and biomedical scientists, it
is clear that the actual implementation of many contem-
porary NTD interventions underutilise the potential of
social inquiry. Such perspectives extend far beyond the
standardised “knowledge”, “attitudes” and “practices”
questionnaire that the social sciences are often reduced
to in global health [139].
In many ways, qualitative and mixed methods research
offers one of the most cost-effective research strategies
for improving programme operations, if findings are
readily incorporated into intervention plans and strat-
egies. There are, of course, numerous challenges to
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used in global health, including for NTDs. As one an-
onymous reviewer pointed out, many of the central ar-
guments of this paper have simply reiterated points
discussed since the 1970s about the relationships between
the social and biomedical sciences [40]. Traditional discip-
linary differences are maintained by different systems of
reward and expectations, further reinforced by funding
bodies and grant cycles and the socio-political nature of
development institutions and organizations. Despite the
rhetoric of multi-disciplinarity, it is clear that entrenched
silos remain. This requires donor agencies and national
governments to conceptualise new ways of conducting re-
search and programmes to move social sciences from an
afterthought to a core component of mainstream donor
and national activities.
Given the large geographical areas of many pro-
grammes, social scientists should also be challenged to
engage more with rapid assessment techniques to sup-
port collaborative team efforts with biomedical scientists
[140]. Concerted efforts to build social science capacity
in ministries and universities in endemic countries should
also continue to be pursued as well as efforts to foster
inter-departmental platforms. Greater reflection on how
to design studies to generate an evidence-base to stimulate
new people-centric intervention strategies and convince
programme managers and policymakers of their practical
benefits are essential, blurring the line between research
and action. Reflection on the acknowledged perils of
“rapid ethnography” need to be negotiated as research
straddles, perhaps uneasily, the segregation of being both
in and out of the public health establishment [141]. While
critical perspectives offer important insights, as Kleinman
[142] commented in The Lancet there is a tendency for
social scientists, driven by structural systems of reward
within their own epistemic communities, to valorise
attacking biomedicine and public health without specific-
ally attempting to improve it. How can social scientists re-
main critical but yet focused on building on, improving
and working with biomedical and development actors?
My final argument relates to the influence of greater
social inquiry on NTD interventions. Giving greater scope
to social perspectives may drive a shift where new ways
of conceptualised and implementing programmes takes
place. At present, much attention on NTDs has focused
on a narrative offering poverty reduction through low-
cost interventions, particularly around MDA. However
there are inherent trade-offs and tensions between these
goals. Promises of “rapid impact packages” are likely to
focus on narrow biomedical approaches that engage lit-
tle with the social determinants of health and illness
[10]. The value of such vertical interventions has been
much debated since the Alma Ata Declaration (1978),
often in highly polarised terms [137]. These tend toframe debates from an either/or perspective. Either pro-
grammes efficiently reduce the health burden of select
illnesses through “narrow biomedical” approaches (or
“military operations”) or they improve health systems by
promoting governance reforms, addressing of social de-
terminants and citizen engagement. In the end, vertical
NTD approaches offer more attractive, a-political and
relatively simplified cause-effect narratives more effect-
ive in mobilise resources and amenable to conventional
data reporting structures. They have also, as Molyneux
and Malecela [3] correctly point out, achieved many
noteworthy public health successes.
Rather the question is: how can these “cost-effective”
strategies also engage in the larger challenge of address-
ing the under-lying drivers to neglected diseases and
help build long-term societal resilience? Many of the re-
search papers reviewed here concluded that more could
have been done to link existing interventions with these
broader social concerns. However, it is one thing to criti-
cise contemporary efforts and quite another to actively
engage with the conundrum of linking public health to
wider developmental challenges and concerns. Focused
on the Avian Influenza response in Asia, Scoones [86]
has shown, in relation to his critique of the One World,
One Health movement, that moving from an expert-
driven, top-down approach to focus on long-term soci-
etal change is difficult to imagine, and yet still more
difficult to put into practice. Global health actors navi-
gate a complex socio-political landscape that requires
framing evidence, mobilising resources and support,
obtaining results and presenting data back to funding
bodies to sustain activities. Broader goals, such as “im-
proving daily living conditions” and “tackling the in-
equitable distribution of wealth, resources and power
at the global, national and local scale” (as recommended
by the WHO’s Commission on the Social Determinants
[26]) present somewhat of a challenge to the expectations,
norms and capabilities that regulate these networks. While
this may seem an obvious point, the realisation that our
ever-expanding scientific knowledge-base has far outpaced
our ability to effectively deal with the social determinants
of disease should challenge funders, practitioners and
researchers to think in more creative ways [143]. Other-
wise poor populations may find that while one NTD has
been eliminated, another one has simply moved in to
take its place.
Beyond simplistic dichotomisations, there is much scope
for disease-specific interventions to engage broadly with
poverty and marginalisation, especially if we conceptualise
NTD control not from the short project cycle but, as Zhang
et al. [144] noted, based on a long-term commitment. This
requires a shift in donor funding that emphasises engaging
in larger societal and developmental processes. A number
of commentaries, mostly from Latin America, have
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and collaborative programmes with other sectors to ddress
the social determinants of health, including education,
housing, water and sanitation, public works, agriculture,
the private sector and economic development [6]. Other
less expansive recommendations emphasise coupling pro-
grammes with the delivery of other health technologies,
such as mosquito net distribution, nutrition programmes
and vitamin A distribution [145-148]. Other opportunities
exist to link the control of zoonotic diseases of poverty to
agricultural development and the provision of animal
health services at the community-level, as shown by the
Stamp out Sleeping Sickness programme in Uganda [56].
This paper agrees with other recent critiques of global
health that have emphasised the tendency for local real-
ities to be put into the margins during planning, imple-
menting and monitoring and evaluating interventions.
Adams et al. [149] called for a movement in “slow re-
search” to parallel the “eat locally” food movement in
order to critically inspect the processes involved and
their multiple associations. Also using metaphor, Panter-
Brick, Eggerman and Tomlinson [150] outlined what
they called the need to master the four “deadly sins” of
global health through a “change of heart”: the coveting
of silo gains, lusting after technological solutions, boast-
ing of small successes and leaving broad promises unful-
filled. Within this wider context and critique, NTD
actors have an opportunity to push boundaries and help
move infectious disease control towards more resilient
and sustainable pathways as envisioned in a One World,
One Health agenda, not to mention influencing the
post-MDG developmental agenda in dynamic, new ways
[5]. Greater attention to social inquiry can help foster
new ways of engagement and orientation. For this to
happen, collaborative and transdisciplinary research needs
to be accompanied by changes in governance structures
(including funding streams) towards more flexible models
that account for diversity of perspectives, seek to under-
stand local complexities and aim to promote adaptation,
reflexivity and learning over time [151,152]. Short project
cycles that dissuade critical analysis, local capacity build-
ing and long-term engagement are problematic. In con-
clusion, the increased attention and funding for NTDs has
the potential to alleviate some of the devastating effects of
major infectious disease on the world’s poor. With bold
new targets established for 2020, however, it is high time
that local realities and social science perspectives are put
at the forefront of intervention planning.Additional file
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